Postnatal oxytocin treatment improves survival and neurodevelopmental outcomes in an animal model of neonatal abstinence syndrome

Postnatal oxytocin treatment improves survival and neurodevelopmental outcomes in an animal model of neonatal abstinence syndrome

Prenatal exposure to drugs of abuse results in neonatal abstinence syndrome (NAS). NAS causes significant morbidity and is associated with costly and lengthy hospitalization. Current pharmacotherapy is suboptimal with no FDA approved treatments. We examined the effect of postnatal oxytocin treatment...

Full description

Bibliographic Details
Main Authors: Dean S. Carson, Simon J. Arnold, Emily R.T. Carson, Conrado Pascual, Xinmin (Simon) Xie
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Comprehensive Psychoneuroendocrinology
Subjects:
Oxytocin
Neonatal abstinence syndrome
Withdrawal
Opioids
Benzodiazepines
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2666497622000340

Internet

http://www.sciencedirect.com/science/article/pii/S2666497622000340

Similar Items